Surveillance of chemotherapy in lung cancer patients on hemodialysis

Multi-institutional retrospective study for advanced lung cancer patients with end-stage kidney disease on hemodialysis (NEJ-042) - NEJ-042 study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036280

Enrollment

100

Registered

2019-04-01

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced lung cancer patients with end-stage kidney disease on hemodialysis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. histologically or cytologically confirmed lung cancer 2. Ineligible for surgery and curative radiotherapy due to cancer status 3. Complicated with end-stage renal failure on hemodialysis

Exclusion criteria

Exclusion criteria: Patient, or family refuses to participate in the study

Design outcomes

Primary

Measure	Time frame
frequency of severe adverse event	—

Secondary

Measure	Time frame
overall survival objective response rate time to treatment failure frequency of each adverse events type of anti-cancer drugs	—

Countries

Japan

Contacts

Public ContactYuji Minegishi

Nippon Medical School Hospital Department of Medical Oncology

yminegis@nms.ac.jp03-3822-2131

Outcome results